Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Visionary Venture Fund is a life sciences venture capital fund based in Newport Beach, California. Established to bridge the gap between capital and insights, the fund targets promising startups in the ophthalmology and medical aesthetics sectors. The firm emphasizes collaboration with Key Opinion Leaders (KOLs) and industry experts to enhance decision-making and reduce investment risks.
Currently, Visionary Venture Fund manages a portfolio of 12 companies, focusing on investments ranging from $5 million to $15 million. The fund primarily invests in U.S.-based companies at the Series A stage and beyond, aiming to support innovative solutions that address unmet market needs. The firm’s commitment to enhancing the success of its portfolio companies is evident through its strategic partnerships and industry insights.
Visionary Venture Fund invests in companies that tackle unmet or underserved markets within the ophthalmology and medical aesthetics sectors. The fund typically targets investments ranging from $5 million to $15 million, focusing on startups from Series A to commercialization. Their investment strategy emphasizes partnerships with KOLs and industry experts, which aids in informed decision-making and risk reduction.
The firm seeks to identify innovative solutions that address significant challenges in eye care and aesthetic medicine. Visionary Venture Fund looks for founders who demonstrate a deep understanding of their market and possess a clear vision for their product's impact. The fund's approach includes a thorough evaluation of the technology's potential and the team's capability to execute their business plan effectively.
Visionary Venture Fund's portfolio includes 12 notable companies, each contributing to advancements in ophthalmology and medical aesthetics:
Jeffry Weinhuff: Managing Partner with extensive experience in venture capital and life sciences.
Dr. Dick Lindstrom: Investment Committee Member, known for his expertise in ophthalmology and medical devices.
Dr. Toby Tyson: Investment Committee Member with a background in healthcare innovation and investment.
Dr. Ehsan Sadri: Investment Committee Member specializing in medical aesthetics and ophthalmology.
Bill Carpou: Investment Committee Member with a focus on strategic investments in life sciences.
Dr. Bob Avery: Investment Committee Member with a strong background in clinical research and development.
Daniel Gil, PhD: Venture Partner with expertise in biotech and pharmaceuticals.
Perry Sternberg: Venture Partner with a focus on early-stage investments in healthcare.
Garrett Hamontree: Partner & CFO, responsible for financial strategy and operations.
To pitch Visionary Venture Fund, startups should use the contact form available on their website, visionaryvc.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. The fund values detailed information about the technology and its potential impact.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, especially from industry contacts or existing portfolio companies.
On March 17, 2026, Visionary Venture Fund published a blog post discussing the Qlosi device, which reduces pupil diameter without significantly impacting the ciliary muscle. This highlights the fund's ongoing engagement with industry advancements and its commitment to sharing insights within its focus areas.
Additionally, the firm continues to expand its portfolio, actively seeking innovative startups in the ophthalmology and medical aesthetics sectors. Their recent activities indicate a proactive approach to identifying and supporting groundbreaking technologies.
What are Visionary Venture Fund's investment criteria?
The fund invests in life sciences companies, particularly in ophthalmology and medical aesthetics, focusing on unmet or underserved markets. They typically invest between $5 million and $15 million in Series A and Series A+ stages.
How can startups apply or pitch to Visionary Venture Fund?
Startups can pitch through the contact form available on their website, visionaryvc.com. It is advisable to include a detailed business plan and information about the team and technology.
What makes Visionary Venture Fund different from other investors?
The firm emphasizes partnerships with Key Opinion Leaders (KOLs) and industry experts, which enhances decision-making and reduces investment risks. This approach provides portfolio companies with valuable insights and connections.
What is the geographic scope of Visionary Venture Fund?
Visionary Venture Fund primarily invests in U.S.-based companies, focusing on the life sciences sector.
What is the fund size and check size range?
While the exact fund size is not disclosed, the fund typically invests between $5 million and $15 million in each portfolio company.
What kind of post-investment involvement does Visionary Venture Fund have?
The firm actively collaborates with portfolio companies, leveraging its network of KOLs and industry experts to support growth and strategic decision-making.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.